Medizinische Universitätsklinik Bochum

www.medunikkh.de

RAMOS Studie EudraCt-Nr: 2016-003850-33; A randomized, multicenter open Label Phase II Trial of Paclitaxel + Ramucirumab versus Paclitaxel alone in patients with squamouscell carcinoma of the oesophagus, refractory or intolerant to combination therapy with Fluoropyrimidine and Platinum-based drugs

Ansprechpartner